PharmD BCPS - NRBO Old VP Operations

NRBODelisted Stock  USD 1.89  0.11  5.50%   

Insider

PharmD BCPS is VP Operations of NRBO Old
Phone857 702 9600
Webhttps://www.neurobopharma.com

NRBO Old Management Efficiency

The company has return on total asset (ROA) of (0.7435) % which means that it has lost $0.7435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6076) %, meaning that it created substantial loss on money invested by shareholders. NRBO Old's management efficiency ratios could be used to measure how well NRBO Old manages its routine affairs as well as how well it operates its assets and liabilities.
NRBO Old currently holds 203 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. NRBO Old has a current ratio of 7.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about NRBO Old's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Timur DoganCardio Diagnostics Holdings
36
Jason DavisVirax Biolabs Group
53
James FosterVirax Biolabs Group
40
Manuel DafonsecaSonnet Biotherapeutics Holdings
N/A
Gordon JDQuoin Pharmaceuticals Ltd
61
MD MBAKiora Pharmaceuticals
52
Cameron ShawVirax Biolabs Group
37
MD DrScAllarity Therapeutics
81
Michael MyersQuoin Pharmaceuticals Ltd
63
MBA JDCardio Diagnostics Holdings
60
Chester IIIRevelation Biosciences
45
Tomasz GeorgeVirax Biolabs Group
40
Steen KnudsenAllarity Therapeutics
64
Quan Vu180 Life Sciences
52
Joan BrownAllarity Therapeutics
70
Carol OdleRevelation Biosciences
N/A
Susan DexterSonnet Biotherapeutics Holdings
70
MD FACPSonnet Biotherapeutics Holdings
67
Melissa ToscaKiora Pharmaceuticals
N/A
Denise CarterQuoin Pharmaceuticals Ltd
56
John CiniSonnet Biotherapeutics Holdings
72
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. Neurobo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. NRBO Old (NRBO) is traded on NASDAQ Exchange in USA and employs 8 people.

Management Performance

NRBO Old Leadership Team

Elected by the shareholders, the NRBO Old's board of directors comprises two types of representatives: NRBO Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NRBO. The board's role is to monitor NRBO Old's management team and ensure that shareholders' interests are well served. NRBO Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NRBO Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
PharmD BCPS, VP Operations
Marshall Woodworth, Principal CFO
HyungHeon Kim, President CEO
Robert Homolka, Senior Operations
Ben MD, CEO Pres
Frank Kondrad, VP Devel
MiKyung Kim, Chief Officer

NRBO Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NRBO Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with NRBO Old

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRBO Old position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRBO Old will appreciate offsetting losses from the drop in the long position's value.

Moving together with NRBO Stock

  0.71QLGN Qualigen TherapeuticsPairCorr
  0.71ASTI Ascent Solar TechnolPairCorr

Moving against NRBO Stock

  0.78GE GE AerospacePairCorr
  0.77NVRO Nevro CorpPairCorr
  0.75IBM International BusinessPairCorr
  0.74T ATT Inc Earnings Call This WeekPairCorr
  0.73JNJ Johnson JohnsonPairCorr
The ability to find closely correlated positions to NRBO Old could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRBO Old when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRBO Old - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRBO Old to buy it.
The correlation of NRBO Old is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRBO Old moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRBO Old moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRBO Old can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in NRBO Stock

If you are still planning to invest in NRBO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NRBO Old's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm